Stock Analysis·← Pickers

SINT

Sintx Technologies, Inc.

Sintx Technologies, Inc. (SINT) is currently in a downtrend, trading below both the 50-day and 200-day moving averages. RSI is at 28.0 (oversold), with 0/3 trend checks passing.

Price
$1.57
2026-07-16
Trend score
0/3
Downtrend
RSI (14)
28.0
Oversold
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

SINT with MA50 and MA200

5.514.523.542.551.5607/3110/2401/2204/1707/15
SINT2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$2.10-25.32% vs price
MA200
$2.99-47.42% vs price
RSI (14)
28.0Oversold zone
MACD Signal
MixedMACD near signal line
Macro Support
Not identifiedNo repeated weekly support zone found
Support Quality
Volume data unavailable
Chart Summary
Trend summary for SINT

Sintx Technologies, Inc. (SINT) currently looks weaker on the chart and is not showing much trend strength. The latest available price is $1.57, and 0 of 3 core trend checks are currently passing. Price is trading below the 50-day moving average by 25.3% and below the 200-day moving average by 47.4%.

Momentum and stretch context

SINT currently has an RSI reading of 28.0, which suggests weaker momentum and a more oversold condition. Some traders may review this kind of setup for a rebound or buy-the-dip idea, but oversold readings by themselves do not guarantee a reversal.

What traders may watch next

For traders reviewing SINT next, the main question is whether weakness is starting to stabilise or whether the chart still looks vulnerable to further downside. Some traders may watch for bounce attempts, but others will want to see stronger proof that the trend is improving before treating the stock as a cleaner setup.

Company profile

About Sintx Technologies, Inc.

Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.

Sector
Healthcare
Industry
Medical - Devices
CEO
Eric K. Olson
Employees
32
Market cap
$4.4M
Beta
0.63
52-week range
$1.55 – $6.78
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
13 Feb 2014
ISIN
US8293927039
CUSIP
829392703
Website
sintx.com
Company profile data from Financial Modeling Prep. SINT listed on NASDAQ.
Share dilution

SINT shares outstanding over time

Tracking total shares outstanding is one way to spot dilution — a rising line means the company has issued more shares (stock-based compensation, secondary offerings, convertible debt), which spreads the same earnings and ownership across more shares. A falling line usually reflects buybacks.

Jun 2019Mar 2026
Shares outstanding (latest)
4.0M
Since Jun 2019
+42978.2%
Trend
More shares outstanding
Historical shares-outstanding data from Financial Modeling Prep. SINT28 data points from Jun 2019 to Mar 2026.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about SINT

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.

SINT Stock Analysis: Downtrend, below MA50 & MA200, RSI 28 oversold | MyStockHarbor